Liver Cancer News Banner

Addressing Liver Cancer Disparities & Advancing Treatment

Global Liver Institute brings you key updates in liver cancer care and health equity. This edition features a 5-year update on the Financial Toxicity Tumor Board Model, highlighting how multidisciplinary collaboration can reduce financial barriers to care. Read through this edition for details about a video series on equitable access to treatment for unresectable hepatocellular carcinoma (HCC), real-world insights into challenges faced by underserved communities, the newest FDA-approved immunotherapy for advanced HCC, and more.


 

Albert B. Sabin Gold Medal Ceremony

Sarah Manes was proud to attend the Albert B. Sabin Gold Medal Ceremony at the National Academy of Sciences Great Hall, celebrating leaders advancing global health through science. We congratulate our colleague, partner, and Liver Cancers Council member, Dr. Livancliff Mbianke of Cameroon, on receiving the Rising Star Award from the Sabin Vaccine Institute. Dr. Livancliff was honored for his dedication to strengthening public health systems and improving health outcomes. We’re grateful to collaborate with him on key liver health initiatives, including #OctoberIs4Livers and Global Fatty Liver Day.

IMG 9930

 

GLI Hosts a Policy Event on the Sidelines of WHA78 – Together for Better Liver Health: Strengthening Public Health Responses to Metabolic Disease, Geneva, Switzerland

This policy event, co-hosted by Global Liver Institute (GLI), the European Association for the Study of the Liver (EASL), and the American Association for the Study of Liver Diseases (AASLD) and endorsed by over 20 international medical societies and organizations, served as a Call to Action for Member States and the WHO to:

  • Formally recognize SLD as a Core NCD, ensuring it is included alongside cardiovascular diseases, diabetes, obesity, and other major NCDs.
  • Expand public awareness campaigns to educate individuals on SLD risk factors and the importance of early detection and treatment.
  • Integrate SLD into NCDs prevention programs, aligning efforts with existing public health initiatives that target obesity, lifestyle interventions, and metabolic health.
  • Support research and data collection to advance understanding of SLD’s epidemiology, prevention, and treatment.

Additionally, during the event, the second edition of the Best Practices in Liver Health Policy report was released. This new edition features five new case studies from Brazil, Japan, Mexico, Spain, and Qatar that demonstrate the integration of liver health into clinical pathways and broader health frameworks.

WHA78 Policy Event 66
WHA78 Policy Event 175
WHA78 Policy Event 205

 

The Financial Toxicity Tumor Board: 5-Year Update on Practice and a Guide to Implementation

Financial distress remains a growing concern for patients with liver cancer, often compounding the challenges of treatment access and adherence. Learn how a multidisciplinary Financial Toxicity Tumor Board (FTTB) model– bringing together clinical, administrative, and supportive care experts- is helping institutions proactively address financial barriers and improve outcomes for patients facing the high costs of cancer care. To learn more about financial navigation and real-world strategies to reduce cancer-related financial burden, watch this recorded conversation, Financial Toxicity: The Cost of Cancer Care.


 

ACCC Knowledge Series: Equitable Access to Quality Care for Unresectable Hepatocellular Carcinoma

As hepatocellular carcinoma (HCC) continues to rise in prevalence and mortality, a collaborative, patient-centered approach to care is critical. A new three-part video series offers valuable insights into key aspects of HCC management, including aligning treatment selection with staging, liver function, and patient goals while highlighting emerging targeted and immunotherapy options.

Hqdefault

 

Navigating Disparities and Challenges in HCC Care

In a recent podcast episode by Cancer Buzz, GI oncology nurse navigator Karen S. Waldrop, BSN, RN, OCN, ONN-CG, and HCC patient Henry Rendon share real-world perspectives on delayed diagnoses, limited specialist access, and the vital role of multidisciplinary teams. Learn how nurse navigators help bridge gaps in care by enhancing patient outreach, improving access, and guiding patients through the complexities of the healthcare system.

600x600bb

 

FDA Approves Nivolumab Plus Ipilimumab for First-Line Metastatic Liver Cancer

The FDA approved the combination of nivolumab and ipilimumab as a first-line treatment for patients with advanced hepatocellular carcinoma (HCC) who are not eligible for surgery. This approval was based on results from the CheckMate 9DW trial, which showed a 31% overall response rate and durable responses in patients receiving the dual immunotherapy. The decision marks a significant advancement in treatment options for metastatic liver cancer, offering a new alternative to standard therapies.


 

touchREVIEWS in Oncology & Haematology – Volume 21, Issue 1 – 2025

This issue brings together a selection of expert perspectives and reviews that reflect the dynamic developments across the oncology and haematology landscape. Topics include advancements in lymphoma management, innovative diagnostic strategies in melanoma, updates on treatment approaches for biliary tract and lung cancers, and evolving therapies in leukaemia and head and neck malignancies.

TouchONC 21.1 Cover Updated HH 1448x2048.jpg

 

Disparities in Liver Cancer Risk and Outcomes in the LGBTQ Community

Emerging research reveals critical liver cancer disparities affecting the LGBTQ community, driven by higher rates of hepatitis, alcohol use, and limited access to care. This literature review highlights gaps in screening, prevention, and treatment, emphasizing the urgent need for targeted interventions and culturally competent healthcare strategies to reduce liver cancer burden in this underserved population.


 

The Frontline Role of Primary Care in Hepatitis B Care

Primary care providers are pivotal in the fight against hepatitis B, a silent yet serious liver infection affecting millions globally. Our latest blog post highlights the vital role of primary care in the early detection, vaccination, and management of hepatitis B. With the CDC recommending universal screening for adults, primary care settings are well-positioned to identify individuals at risk and initiate timely interventions. By integrating hepatitis B screening and education into routine care, primary care professionals can significantly reduce the burden of liver disease and improve patient outcomes.

Picori R2G2

 


 

For more information about the Liver Cancers Council or to learn more about joining, please visit https://globalliver.org/liver-cancers-council/ or email cancer@globalliver.org